Literature DB >> 18040064

Inflammation and oxidative stress in obstructive sleep apnea syndrome.

Carlo Selmi1, Nicola Montano, Raffaello Furlan, Carl L Keen, M Eric Gershwin.   

Abstract

Similar to obesity, with which it is closely associated, obstructive sleep apnea syndrome (OSAS) is rapidly becoming a worldwide epidemic. Current knowledge of its pathogenesis has been significantly enriched by numerous experimental studies that have demonstrated an important role of oxidative stress and inflammation. Furthermore, new and exciting data strongly connect these two components in the perpetuation of the condition via the overexpression of nuclear factor kappaB. Experimental data support the hypothesis that nutrition might represent a promising future approach with antioxidants currently being good candidates for the modulation of cardiovascular sequelae, although weight reduction and controlled positive airway pressure remain the only established treatments for OSAS. We discuss herein the recent literature that illustrates these new paradigms and speculate on possible implications and future scenarios.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040064     DOI: 10.3181/0704-MR-103

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  16 in total

Review 1.  Biomarkers in Sleep Apnea and Heart Failure.

Authors:  Ying Y Zhao; Reena Mehra
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 2.  Obstructive sleep apnea syndrome and fatty liver: association or causal link?

Authors:  Mohamed-H Ahmed; Christopher-D Byrne
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  Increased systemic inflammation overnight correlates with insulin resistance among children evaluated for obstructive sleep apnea.

Authors:  Mark D Deboer; James P Mendoza; Lei Liu; Gabriele Ford; Pearl L Yu; Benjamin M Gaston
Journal:  Sleep Breath       Date:  2011-03-01       Impact factor: 2.816

Review 4.  Therapeutic potential of intermittent hypoxia: a matter of dose.

Authors:  Angela Navarrete-Opazo; Gordon S Mitchell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-17       Impact factor: 3.619

5.  Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea.

Authors:  Darlan Pase da Rosa; Luiz Felipe Forgiarini; Mariel Barbachan e Silva; Cíntia Zappe Fiori; Cristiano Feijó Andrade; Dênis Martinez; Norma Possa Marroni
Journal:  Inflamm Res       Date:  2014-11-08       Impact factor: 4.575

6.  Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure.

Authors:  Peter Celec; Július Hodosy; Michal Behuliak; Roland Pálffy; Roman Gardlík; Lukáč Halčák; Imrich Mucska
Journal:  Sleep Breath       Date:  2011-03-26       Impact factor: 2.816

7.  Exhaled nitric oxide from the central airway and alveoli in OSAHS patients: the potential correlations and clinical implications.

Authors:  Jie Liu; Zheng Li; Zilong Liu; Fen Zhu; Wenjing Li; Hong Jiang; Xiaodan Wu; Yuanlin Song; Shanqun Li; Chunxue Bai
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

8.  Oxidative and carbonyl stress in pregnant women with obstructive sleep apnea.

Authors:  Nazia Khan; Geralyn Lambert-Messerlian; Joao Filipe Monteiro; Julius Hodosy; Ľubomíra Tóthová; Peter Celec; Elizabeth Eklund; Patrizia Curran; Ghada Bourjeily
Journal:  Sleep Breath       Date:  2017-02-24       Impact factor: 2.816

Review 9.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 10.  Metabolic consequences of sleep-disordered breathing.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  ILAR J       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.